Molecular Pathways Associated with Ibrutinib Resistance in Mantle Cell Lymphoma

被引：0
|
作者：
Zhang, Liang
Nomie, Krystle
Zhang, Shaojun
Liu, Yang
Guo, Hui
Huang, Shengjian
Wang, Jeffrey
Lopez, Elyse
Zhang, Hui
Lorence, Elizabeth A.
Merolle, Maria
Balaji, Swathi
Ahmed, Makhdum
Jiang, Changying
Wang, Linghua
Wang, Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2738
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oncogenic MALT1 Promotes Cell Survival and Mediates Ibrutinib Resistance and Ibrutinib-Venetoclax Resistance in Mantle Cell Lymphoma
    Jiang, Vivian Changying
    Lian, Junwei
    Huang, Shengjian
    Zhang, Shaojun
    Liu, Yang
    Wang, Linghua
    Wang, Michael
    BLOOD, 2020, 136
  • [22] Mechanism of action of Ibrutinib in mantle cell lymphoma
    Sun, Zhijian
    Zhou, Dongping
    Wei, Min
    Luo, Lusong
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Ibrutinib associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma
    Furtado, M. V.
    Munneke, B.
    Wang, M.
    Beaupre, D.
    McGreivy, J.
    Rule, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 64 - 64
  • [24] CDK9 Inhibition Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma (MCL)
    Roleder, Carly
    Dominguez, Edward C.
    Chen, Andrew
    Ball, Brian J.
    Danilova, Olga
    Danilov, Alexey
    BLOOD, 2023, 142
  • [25] Targeting PRMT5 to Circumvent Acquired Ibrutinib Resistance in Mantle Cell Lymphoma
    Sloan, Shelby
    Brown, Fiona
    Chung, Ji Hyun
    Prouty, Alexander
    Wheeler, Esther
    Harrington, Bonnie K.
    Brooks, Eric
    Yilmaz, Ayse S.
    Ozer, Hatice G.
    Byrd, John C.
    Chen-Kiang, Selina
    Di Liberto, Maurizio
    Lapalombella, Rosa
    Vaddi, Kris
    Scherle, Peggy
    Youssef, Youssef
    Baiocchi, Robert A.
    Alinari, Lapo
    BLOOD, 2019, 134
  • [26] DNMT3A-Mediated Oxidative Phosphorylation and Ibrutinib Resistance in Mantle Cell Lymphoma
    Nguyet Minh Hoang
    Liu, Yunxia
    Rui, Lixin
    BLOOD, 2022, 140 : 8762 - 8763
  • [27] Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
    Rishu Agarwal
    Yih-Chih Chan
    Constantine S. Tam
    Tane Hunter
    Dane Vassiliadis
    Charis E. Teh
    Rachel Thijssen
    Paul Yeh
    Stephen Q. Wong
    Sarah Ftouni
    Enid Y. N. Lam
    Mary Ann Anderson
    Christiane Pott
    Omer Gilan
    Charles C. Bell
    Kathy Knezevic
    Piers Blombery
    Kathleen Rayeroux
    Adrian Zordan
    Jason Li
    David C. S. Huang
    Meaghan Wall
    John F. Seymour
    Daniel H. D. Gray
    Andrew W. Roberts
    Mark A. Dawson
    Sarah-Jane Dawson
    Nature Medicine, 2019, 25 : 119 - 129
  • [28] Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib
    Sun, Kai
    Kasparian, Saro
    Iyer, Swaminathan
    Pingali, Sai Ravi
    ECANCERMEDICALSCIENCE, 2018, 12
  • [29] Can we improve on ibrutinib in mantle cell lymphoma?
    Rule, Simon
    LANCET HAEMATOLOGY, 2018, 5 (03): : E98 - E99
  • [30] Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma
    Furtado, Michelle
    Wang, Michael L.
    Munneke, Brian
    McGreivy, Jesse
    Beaupre, Darrin M.
    Rule, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (01) : 131 - 134
12345